Literature DB >> 2795470

Differential actions of cocaine and amphetamine on dorsal raphe neurons in vitro.

Z Z Pan1, J T Williams.   

Abstract

Intracellular recordings of membrane potential were made from neurons in nucleus dorsal raphe in the rat brain slice. Cocaine (300 nM-30 microM) caused a concentration-dependent hyperpolarization of the membrane potential, with a maximum effect of 13.3 +/- 2.2 mV (N = 6) and an EC50 of 4.2 microM. This action was antagonized by spiperone (1 microM), suggesting that the hyperpolarization was mediated indirectly through endogenous 5-hydroxytryptamine (5-HT). Cocaine (300 nM) increased the time constant for decay (tau 2) of the 5-HT inhibitory postsynaptic potential (IPSP) from 432 +/- 57 msec to 708 +/- 81 msec (N = 14); 10 microM increased tau 2 by about 9-fold. Amphetamine (100 nM-10 microM) caused a depolarization that was antagonized by prazosin (100 nM). In slices taken from reserpine-treated animals (5 mg/kg, 12 hr), the 5-HT-mediated IPSP, the noradrenaline-mediated slow excitatory postsynaptic potential and the amphetamine-induced depolarization were absent. These results indicate that the amphetamine-induced depolarization resulted from the release of endogenous noradrenaline. In the presence of prazosin (100 nM), amphetamine caused a hyperpolarization at a threshold concentration of 10 microM, had an EC50 of 26 microM and a maximum effect of 10 +/- 0.9 mV (N = 8). This hyperpolarization as well as the cocaine-induced hyperpolarization were not reduced by prior treatment with reserpine. Amphetamine (10 microM) caused a 2.2-fold increase in the time constant of decay of the IPSP with no change in the amplitude.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2795470

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Block of a Ca(2+)-activated potassium channel by cocaine.

Authors:  L S Premkumar
Journal:  J Membr Biol       Date:  2005-04       Impact factor: 1.843

2.  Presynaptic nicotinic receptors facilitate monoaminergic transmission.

Authors:  X Li; D G Rainnie; R W McCarley; R W Greene
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

Review 3.  Contributions of serotonin in addiction vulnerability.

Authors:  L G Kirby; F D Zeeb; C A Winstanley
Journal:  Neuropharmacology       Date:  2011-04-03       Impact factor: 5.250

Review 4.  5-HT1A Receptor-Mediated Autoinhibition and the Control of Serotonergic Cell Firing.

Authors:  Rodrigo Andrade; Daniel Huereca; Joseph G Lyons; Elaine M Andrade; Kelly M McGregor
Journal:  ACS Chem Neurosci       Date:  2015-05-26       Impact factor: 4.418

5.  Vasoconstriction of guinea-pig submucosal arterioles following sympathetic nerve stimulation is mediated by the release of ATP.

Authors:  R J Evans; A Surprenant
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

6.  Actions of cocaine on rat dopaminergic neurones in vitro.

Authors:  M G Lacey; N B Mercuri; R A North
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

7.  Mechanisms of 5-HT1A receptor-mediated transmission in dorsal raphe serotonin neurons.

Authors:  Nicholas A Courtney; Christopher P Ford
Journal:  J Physiol       Date:  2015-12-30       Impact factor: 5.182

8.  Alpha 1-adrenoceptors in rat dorsal raphe neurons: regulation of two potassium conductances.

Authors:  Z Z Pan; T J Grudt; J T Williams
Journal:  J Physiol       Date:  1994-08-01       Impact factor: 5.182

9.  Real time detection of acute (IP) cocaine-enhanced dopamine and serotonin release in ventrolateral nucleus accumbens of the behaving Norway rat.

Authors:  P A Broderick; E P Kornak; F Eng; R Wechsler
Journal:  Pharmacol Biochem Behav       Date:  1993-11       Impact factor: 3.533

10.  Cocaine's colocalized effects on synaptic serotonin and dopamine in ventral tegmentum in a reinforcement paradigm.

Authors:  P A Broderick
Journal:  Pharmacol Biochem Behav       Date:  1992-08       Impact factor: 3.533

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.